GlassScriptPhysician profile
Ana Stubbs
NPI 1689233835
$748.32
in general payments reported to CMS, 2019-2025
14 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.80 · 2022: $24.40 · 2023: $48.34 · 2024: $250 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $370.84 | 2024-2025 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Mayne Pharma Commercial LLC | $76.12 | 2025 | |
| Abbvie INC. | $63.05 | 2021-2022 | |
| Dexcom, INC. | $29.42 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $28.93 | 2023 | Keytruda, Lenvima |
| Boston Scientific Corporation | $27.83 | 2025 | Ekosonic |
| Xeris Pharmaceuticals, INC. | $23.37 | 2024 | Gvoke Hypopen |
| Coloplast Corp | $22.02 | 2025 | |
| Viiv Healthcare Company | $21.67 | 2025 | Apretude |
| Sanofi Pasteur INC. | $20.86 | 2024 | |
| Eisai INC. | $19.41 | 2023 | |
| Meditrina | $16.14 | 2025 | |
| Gilead Sciences, INC. | $15.51 | 2025 | |
| Myovant Sciences INC. | $13.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Stubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.